Reduction of oxidative stress by carvedilol: role in maintenance of ischaemic myocardium viability.

[1]  R. Ferrari,et al.  Changes in oxidative stress and cellular redox potential during myocardial storage for transplantation: experimental studies. , 1999, The Journal of heart and lung transplantation : the official publication of the International Society for Heart Transplantation.

[2]  R. Collins,et al.  Indications for ACE inhibitors in the early treatment of acute myocardial infarction: systematic overview of individual data from 100,000 patients in randomized trials. ACE Inhibitor Myocardial Infarction Collaborative Group. , 1998, Circulation.

[3]  G. Feuerstein,et al.  Protective effects of carvedilol in the myocardium. , 1997, The American journal of cardiology.

[4]  R. Berge,et al.  Carvedilol improves function and reduces infarct size in the feline myocardium by protecting against lethal reperfusion injury. , 1996, European journal of pharmacology.

[5]  R. Berge,et al.  Carvedilol protects against lethal reperfusion injury through antiadrenergic mechanisms. , 1996, Journal of cardiovascular pharmacology.

[6]  T. Yue,et al.  Carvedilol, a new beta adrenoreceptor blocker and free radical scavenger, attenuates myocardial ischemia-reperfusion injury in hypercholesterolemic rabbits. , 1996, The Journal of pharmacology and experimental therapeutics.

[7]  G. Feuerstein,et al.  Carvedilol, a novel multiple action antihypertensive agent with antioxidant activity and the potential for myocardial and vascular protection. , 1995, European heart journal.

[8]  S. Yusuf,et al.  Overview of Randomized Trials of Angiotensin-Converting Enzyme Inhibitors on Mortality and Morbidity in Patients With Heart Failure , 1995 .

[9]  R. Ferrari,et al.  Extraction and assay of creatine phosphate, purine, and pyridine nucleotides in cardiac tissue by reversed-phase high-performance liquid chromatography. , 1994, Analytical biochemistry.

[10]  T. Yue,et al.  Myocardial protection by the novel vasodilating beta-blocker, carvedilol: potential relevance of anti-oxidant activity. , 1993, Journal of hypertension. Supplement : official journal of the International Society of Hypertension.

[11]  Hung‐Yuan Cheng,et al.  Carvedilol, a new vasodilator and beta adrenoceptor antagonist, is an antioxidant and free radical scavenger. , 1992, The Journal of pharmacology and experimental therapeutics.

[12]  G. Feuerstein,et al.  Cardioprotective effects of carvedilol, a novel beta adrenoceptor antagonist with vasodilating properties, in anaesthetised minipigs: comparison with propranolol. , 1992, Cardiovascular research.

[13]  T. Yue,et al.  Carvedilol, a new beta-adrenoceptor antagonist and vasodilator antihypertensive drug, inhibits superoxide release from human neutrophils. , 1992, European journal of pharmacology.

[14]  E. F. Smith,et al.  Myocardial protection with carvedilol. , 1992, Journal of cardiovascular pharmacology.

[15]  O. Aruoma,et al.  Free radical scavenging and inhibition of lipid peroxidation by beta-blockers and by agents that interfere with calcium metabolism. A physiologically-significant process? , 1991, Biochemical pharmacology.

[16]  F. Barone,et al.  Carvedilol (Kredex) reduces infarct size in a canine model of acute myocardial infarction. , 1991, Pharmacology.

[17]  O. Alfieri,et al.  Occurrence of oxidative stress during reperfusion of the human heart. , 1990, Circulation.

[18]  J. Zweier.  Measurement of superoxide-derived free radicals in the reperfused heart. Evidence for a free radical mechanism of reperfusion injury. , 1988, The Journal of biological chemistry.

[19]  R. Ferrari,et al.  The role of glutathione status in the protection against ischaemic and reperfusion damage: effects of N-acetyl cysteine. , 1988, Journal of molecular and cellular cardiology.

[20]  T. Slater,et al.  Direct detection of free radicals in the reperfused rat heart using electron spin resonance spectroscopy. , 1987, Circulation research.

[21]  P. J. Simpson,et al.  Free radicals and myocardial ischemia and reperfusion injury. , 1987, The Journal of laboratory and clinical medicine.

[22]  R. Ferrari,et al.  Oxygen-mediated myocardial damage during ischaemia and reperfusion: role of the cellular defences against oxygen toxicity. , 1985, Journal of Molecular and Cellular Cardiology.

[23]  K. Lamka,et al.  Adenine Nucleotide Metabolism and Compartmentalization in Isolated Adult Rat Heart Cells , 1984, Circulation research.

[24]  B. Lucchesi,et al.  Protective effects of β-adrenergic blockade in isolated ischemic hearts☆ , 1980 .

[25]  M. M. Bradford.  A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. , 1976, Analytical biochemistry.

[26]  W. Kübler,et al.  Regulation of glycolysis in the ischemic and the anoxic myocardium. , 1970, Journal of molecular and cellular cardiology.

[27]  F. Tietze.  Enzymic method for quantitative determination of nanogram amounts of total and oxidized glutathione: applications to mammalian blood and other tissues. , 1969, Analytical biochemistry.

[28]  J. Sedlák,et al.  Estimation of total, protein-bound, and nonprotein sulfhydryl groups in tissue with Ellman's reagent. , 1968, Analytical biochemistry.

[29]  D. Garcia-Dorado,et al.  Cardiovascular Research , 1966 .

[30]  I. T. Oliver.  A spectrophotometric method for the determination of creatine phosphokinase and myokinase. , 1955, The Biochemical journal.